TNFRSF4 and dermatitis: Notably, at 10 weeks of age, the Brd4fl/fl Ox40-Cre mice that received CD45.1+ Tregs had markedly reduced dermatitis and hair loss; similar findings were observed at 14 weeks of age, which contrasted sharply with those without Treg transfer (Figure 7E).